glp-1 for perimenopause weight gain Understanding Benefits Symptoms Perimenopause Weight Gain: The GLP-1,

Blood Coagul Fibrinolysis (2000) 11:6738

In general, and similar to FDA-approved labeling for GLP-1 weight-management medications, you may be considered for a GLP-1 prescription if you: Have a BMI of 30 or higher (obesity), or Have a BMI between 2729.9 (overweight) plus a weight-related health condition Weight-related conditions can include high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, or PCOS (Polycystic Ovary Syndrome), for example

This way, food is digested at a slower pace, leading to a slow yet steady release of glucose into the bloodstream

By understanding your condition better and gaining insight into available natural treatment options, youll be better equipped to navigate your health journey

Semaglutide requires gradual dose increases

Author: Allison Nathan, Jenny Grimberg and Ashley Rhodes